Open Access
Issue
Parasite
Volume 32, 2025
Article Number 12
Number of page(s) 26
DOI https://doi.org/10.1051/parasite/2025005
Published online 21 February 2025
  1. Adenowo AF, Oyinloye BE, Ogunyinka BI, Kappo AP. 2015. Impact of human schistosomiasis in sub-Saharan Africa. Brazilian Journal of Infectious Diseases, 19(2), 196–205. [CrossRef] [Google Scholar]
  2. Bartlett AW, Sousa-Figueiredo JC, van Goor RC, Monaghan P, Lancaster W, Mugizi R, Mendes EP, Nery SV, Lopes S. 2022. Burden and factors associated with schistosomiasis and soil-transmitted helminth infections among school-age children in Huambo, Uige and Zaire provinces, Angola. Infectious Diseases of Poverty, 11(1), 73. [CrossRef] [PubMed] [Google Scholar]
  3. Bergquist R, Yang GJ, Knopp S, Utzinger J, Tanner M. 2015. Surveillance and response: Tools and approaches for the elimination stage of neglected tropical diseases. Acta Tropica, 141(Pt B), 229–234. [CrossRef] [PubMed] [Google Scholar]
  4. Bradley M, Taylor R, Jacobson J, Guex M, Hopkins A, Jensen J, Leonard L, Waltz J, Kuykens L, Sow PS, Madeja UD, Hida T, Ole-Moiyoi K, King J, Argaw D, Mohamed J, Polo MR, Yajima A, Ottesen E. 2021. Medicine donation programmes supporting the global drive to end the burden of neglected tropical diseases. Transactions of the Royal Society of Tropical Medicine and Hygiene, 115(2), 136–144. [CrossRef] [PubMed] [Google Scholar]
  5. Christinet V, Lazdins-Helds JK, Stothard JR, Reinhard-Rupp J. 2016. Female genital schistosomiasis (FGS): from case reports to a call for concerted action against this neglected gynaecological disease. International Journal for Parasitology, 46(7), 395–404. [CrossRef] [PubMed] [Google Scholar]
  6. GBD 2019 Diseases and Injuries Collaborators. 2020. Global burden of 369 diseases and injuries in 204 countries and territories, 1990–2019: a systematic analysis for the Global Burden of Disease Study 2019. Lancet, 396(10258), 1204–1222. [CrossRef] [PubMed] [Google Scholar]
  7. Devi S. 2024. Challenges for infant schistosomiasis treatment. Lancet, 403(10445), 2682. [CrossRef] [PubMed] [Google Scholar]
  8. Díaz AV, Walker M, Webster JP. 2023. Reaching the World Health Organization elimination targets for schistosomiasis: the importance of a One Health perspective. Philosophical Transactions of the Royal Society B – Biological Sciences, 378(1887), 20220274. [CrossRef] [PubMed] [Google Scholar]
  9. Gabaake KP, Phaladze NA, Lucero-Prisno Iii DE, Thakadu OT. 2022. Assessment of awareness and knowledge of schistosomiasis among school-aged children (6–13 years) in the Okavango Delta, Botswana. Global Health Research and Policy, 7(1), 36. [CrossRef] [PubMed] [Google Scholar]
  10. Gryseels B. 2012. Schistosomiasis. Infectious Disease Clinics of North America, 26(2), 383–397. [CrossRef] [PubMed] [Google Scholar]
  11. Gryseels B, Polman K, Clerinx J, Kestens L. 2006. Human schistosomiasis. Lancet, 368(9541), 1106–1118. [CrossRef] [PubMed] [Google Scholar]
  12. Holowka T, Castilho TM, Garcia AB, Sun T, McMahon-Pratt D, Bucala R. 2016. Leishmania-encoded orthologs of macrophage migration inhibitory factor regulate host immunity to promote parasite persistence. FASEB Journal, 30(6), 2249–2265. [CrossRef] [PubMed] [Google Scholar]
  13. Hong A, Umar A, Chen H, Yu Z, Huang J. 2024. Advances in the study of the interaction between schistosome infections and the host’s intestinal microorganisms. Parasites & Vectors, 17(1), 185. [CrossRef] [PubMed] [Google Scholar]
  14. Hotez PJ, Alvarado M, Basáñez MG, Bolliger I, Bourne R, Boussinesq M, Brooker SJ, Brown AS, Buckle G, Budke CM, Carabin H, Coffeng LE, Fèvre EM, Fürst T, Halasa YA, Jasrasaria R, Johns NE, Keiser J, King CH, Lozano R, Murdoch ME, O’Hanlon S, Pion SD, Pullan RL, Ramaiah KD, Roberts T, Shepard DS, Smith JL, Stolk WA, Undurraga EA, Utzinger J, Wang M, Murray CJ, Naghavi M. 2014. The global burden of disease study 2010: interpretation and implications for the neglected tropical diseases. PLoS Neglected Tropical Diseases, 8(7), e2865. [CrossRef] [PubMed] [Google Scholar]
  15. Kim YE, Jung YS, Ock M, Yoon SJ. 2022. DALY Estimation Approaches: Understanding and using the incidence-based approach and the prevalence-based approach. Journal of Preventive Medicine and Public Health, 55(1), 10–18. [CrossRef] [PubMed] [Google Scholar]
  16. King CH, Bertsch D. 2015. Historical perspective: snail control to prevent schistosomiasis. PLoS Neglected Tropical Diseases, 9(4), e0003657. [CrossRef] [PubMed] [Google Scholar]
  17. King CH, Galvani AP. 2018. Underestimation of the global burden of schistosomiasis. Lancet, 391(10118), 307–308. [CrossRef] [PubMed] [Google Scholar]
  18. Lehane M, Alfaroukh I, Bucheton B, Camara M, Harris A, Kaba D, Lumbala C, Peka M, Rayaisse JB, Waiswa C, Solano P, Torr S. 2016. Tsetse control and the elimination of Gambian sleeping sickness. PLOS Neglected Tropical Diseases, 10(4), e0004437. [CrossRef] [PubMed] [Google Scholar]
  19. Liu C, Fisher D, Pronyuk K, Musabaev E, Thu Hien NT, Dang Y, Zhao L. 2024. Therapeutic potential of natural products in schistosomiasis-associated liver fibrosis. Frontiers in Pharmacology, 15, 1332027. [CrossRef] [PubMed] [Google Scholar]
  20. Maslow JN. 2019. Challenges and solutions in the development of vaccines against emerging and neglected infectious diseases. Human Vaccines & Immunotherapeutics, 15(10), 2230–2234. [CrossRef] [PubMed] [Google Scholar]
  21. Mawa PA, Kincaid-Smith J, Tukahebwa EM, Webster JP, Wilson S. 2021. Schistosomiasis morbidity hotspots: Roles of the human host, the parasite and their interface in the development of severe morbidity. Frontiers in Immunology, 12, 635869. [CrossRef] [PubMed] [Google Scholar]
  22. Mduluza T, Jones C, Osakunor DNM, Lim R, Kuebel JK, Phiri I, Manangazira P, Tagwireyi P, Mutapi F. 2020. Six rounds of annual praziquantel treatment during a national helminth control program significantly reduced schistosome infection and morbidity levels in a cohort of schoolchildren in Zimbabwe. PLoS Neglected Tropical Diseases, 14(6), e0008388. [CrossRef] [PubMed] [Google Scholar]
  23. Melo GBT, Angulo-Tuesta A, Silva END, Santos TDS, Uchimura LYT, Obara MT. 2023. Evolution of research funding for neglected tropical diseases in Brazil, 2004–2020. PLoS Neglected Tropical Diseases, 17(3), e0011134. [CrossRef] [PubMed] [Google Scholar]
  24. Murta FLG, Massara CL, Rodrigues MG, Beck L, Favre TC. 2022. Teachers as multipliers of knowledge about schistosomiasis: a possible approach for health education programmes. BMC Infectious Diseases, 22(1), 853. [CrossRef] [PubMed] [Google Scholar]
  25. Rasoamanamihaja CF, Rakotoarivelo RA, Edosoa G, Rasamoelina T, Montresor A, Marchese V, Fusco D. 2023. Schistosomiasis elimination in Madagascar: challenges and opportunities for implementing the new WHO guidelines. BMJ Global Health, 8(8), e012598. [CrossRef] [PubMed] [Google Scholar]
  26. Rohr JR, Sack A, Bakhoum S, Barrett CB, Lopez-Carr D, Chamberlin AJ, Civitello DJ, Diatta C, Doruska MJ, De Leo GA, Haggerty CJE, Jones IJ, Jouanard N, Lund AJ, Ly AT, Ndione RA, Remais JV, Riveau G, Schacht AM, Seck M, Senghor S, Sokolow SH, Wolfe C. 2023. A planetary health innovation for disease, food and water challenges in Africa. Nature, 619(7971), 782–787. [CrossRef] [PubMed] [Google Scholar]
  27. Semenza JC, Rocklöv J, Ebi KL. 2022. Climate change and cascading risks from infectious disease. Infectious Diseases and Therapy, 11(4), 1371–1390. [CrossRef] [PubMed] [Google Scholar]
  28. Siddiqui AJ, Bhardwaj J, Saxena J, Jahan S, Snoussi M, Bardakci F, Badraoui R, Adnan M. 2023. A critical review on human malaria and schistosomiasis vaccines: Current state, recent advancements, and developments. Vaccines, 11(4), 792. [CrossRef] [PubMed] [Google Scholar]
  29. Sokolow SH, Wood CL, Jones IJ, Lafferty KD, Kuris AM, Hsieh MH, De Leo GA. 2018. To reduce the global burden of human schistosomiasis, use “old fashioned” snail control. Trends in Parasitology, 34(1), 23–40. [CrossRef] [PubMed] [Google Scholar]
  30. Steinmann P, Keiser J, Bos R, Tanner M, Utzinger J. 2006. Schistosomiasis and water resources development: systematic review, meta-analysis, and estimates of people at risk. Lancet Infectious Diseases, 6(7), 411–425. [CrossRef] [Google Scholar]
  31. Wang L, Utzinger J, Zhou XN. 2008. Schistosomiasis control: experiences and lessons from China. Lancet, 372(9652), 1793–1795. [CrossRef] [PubMed] [Google Scholar]
  32. Wang W, Wang L, Liang YS. 2012. Susceptibility or resistance of praziquantel in human schistosomiasis: a review. Parasitology Research, 111(5), 1871–1877. [CrossRef] [PubMed] [Google Scholar]
  33. Wu W, Huang Y. 2013. Application of praziquantel in schistosomiasis japonica control strategies in China. Parasitology Research, 112(3), 909–915. [CrossRef] [PubMed] [Google Scholar]
  34. Xu J, Li SZ, Zhang LJ, Bergquist R, Dang H, Wang Q, Lv S, Wang TP, Lin DD, Liu JB, Ren GH, Yang K, Liu Y, Dong Y, Zhang SQ, Zhou XN. 2020. Surveillance-based evidence: elimination of schistosomiasis as a public health problem in the Peoples’ Republic of China. Infectious Diseases of Poverty, 9(1), 63. [CrossRef] [PubMed] [Google Scholar]
  35. Yang P, Cheng P, Zhang N, Luo D, Xu B, Zhang H. 2024. Statistical machine learning models for prediction of China’s maritime emergency patients in dynamic: ARIMA model, SARIMA model, and dynamic Bayesian network model. Frontiers in Public Health, 12, 1401161. [CrossRef] [PubMed] [Google Scholar]
  36. Zhang YQ, Li XX, Li WB, Jiang JG, Zhang GL, Zhuang Y, Xu JY, Shi J, Sun DY. 2020. Analysis and predication of tuberculosis registration rates in Henan Province, China: an exponential smoothing model study. Infectious Diseases of Poverty, 9(1), 123. [CrossRef] [PubMed] [Google Scholar]

Current usage metrics show cumulative count of Article Views (full-text article views including HTML views, PDF and ePub downloads, according to the available data) and Abstracts Views on Vision4Press platform.

Data correspond to usage on the plateform after 2015. The current usage metrics is available 48-96 hours after online publication and is updated daily on week days.

Initial download of the metrics may take a while.